No Data
No Data
At US$51.23, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Strong Market Reclaim and Innovative Pipeline Underpin Buy Rating for Tandem Diabetes Care
Tandem Diabetes Care Initiated at Buy by Redburn Atlantic
Tandem Diabetes Care Initiated at Buy by Redburn Atlantic
Express News | Redburn Atlantic Initiates Coverage On Tandem Diabetes Care With Buy Rating, Announces Price Target of $60
Express News | Tandem Diabetes Care: Tandem Mobi Insulin Pump With Control-Iq Technology Fully Compatible With Dexcom G7 & G6 Cgm Systems
Tandem Mobi Insulin Pump Now Compatible With Dexcom G7 CGM
PDF Version SAN DIEGO--(BUSINESS WIRE)--May 29, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ t
No Data